177 related articles for article (PubMed ID: 32410372)
1. A second-generation glucagon-like peptide-1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models.
Borner T; Shaulson ED; Tinsley IC; Stein LM; Horn CC; Hayes MR; Doyle RP; De Jonghe BC
Diabetes Obes Metab; 2020 Oct; 22(10):1729-1741. PubMed ID: 32410372
[TBL] [Abstract][Full Text] [Related]
2. Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis.
Borner T; Workinger JL; Tinsley IC; Fortin SM; Stein LM; Chepurny OG; Holz GG; Wierzba AJ; Gryko D; Nexø E; Shaulson ED; Bamezai A; Da Silva VAR; De Jonghe BC; Hayes MR; Doyle RP
Cell Rep; 2020 Jun; 31(11):107768. PubMed ID: 32553160
[TBL] [Abstract][Full Text] [Related]
3. A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents.
Mietlicki-Baase EG; Liberini CG; Workinger JL; Bonaccorso RL; Borner T; Reiner DJ; Koch-Laskowski K; McGrath LE; Lhamo R; Stein LM; De Jonghe BC; Holz GG; Roth CL; Doyle RP; Hayes MR
Diabetes Obes Metab; 2018 May; 20(5):1223-1234. PubMed ID: 29327400
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Optimization, and Biological Evaluation of Corrinated Conjugates of the GLP-1R Agonist Exendin-4.
Tinsley IC; Borner T; Swanson ML; Chepurny OG; Doebley SA; Kamat V; Sweet IR; Holz GG; Hayes MR; De Jonghe BC; Doyle RP
J Med Chem; 2021 Mar; 64(6):3479-3492. PubMed ID: 33677970
[TBL] [Abstract][Full Text] [Related]
5. Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew).
Chan SW; Lin G; Yew DT; Yeung CK; Rudd JA
Neuropharmacology; 2013 Jul; 70():141-7. PubMed ID: 23357334
[TBL] [Abstract][Full Text] [Related]
6. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?
Borner T; Tinsley IC; Doyle RP; Hayes MR; De Jonghe BC
Br J Pharmacol; 2022 Feb; 179(4):542-556. PubMed ID: 34363224
[TBL] [Abstract][Full Text] [Related]
8. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
9. Differential hypoglycaemic, anorectic, autonomic and emetic effects of the glucagon-like peptide receptor agonist, exendin-4, in the conscious telemetered ferret.
Lu Z; Percie Du Sert N; Chan SW; Yeung CK; Lin G; Yew DT; Andrews PL; Rudd JA
J Transl Med; 2014 Dec; 12():327. PubMed ID: 25491123
[TBL] [Abstract][Full Text] [Related]
10. The differential antiemetic properties of GLP-1 receptor antagonist, exendin (9-39) in Suncus murinus (house musk shrew).
Chan SW; Lu Z; Lin G; Yew DT; Yeung CK; Rudd JA
Neuropharmacology; 2014 Aug; 83():71-8. PubMed ID: 24726308
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 receptors are involved in the GLP-1 (7-36) amide-induced modulation of glucose homoeostasis, emesis and feeding in Suncus murinus (house musk shrew).
Lu Z; Chan SW; Tu L; Ngan MP; Rudd JA
Eur J Pharmacol; 2020 Dec; 888():173528. PubMed ID: 32871177
[TBL] [Abstract][Full Text] [Related]
12. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
[TBL] [Abstract][Full Text] [Related]
13. Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis.
Milliken BT; Elfers C; Chepurny OG; Chichura KS; Sweet IR; Borner T; Hayes MR; De Jonghe BC; Holz GG; Roth CL; Doyle RP
J Med Chem; 2021 Jan; 64(2):1127-1138. PubMed ID: 33449689
[TBL] [Abstract][Full Text] [Related]
14. Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects.
Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Yabe D; Inagaki N
J Diabetes Investig; 2020 Nov; 11(6):1448-1456. PubMed ID: 32323451
[TBL] [Abstract][Full Text] [Related]
15. Prolonged exendin-4 administration stimulates pituitary-adrenocortical axis of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Neri G; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
Int J Mol Med; 2003 Oct; 12(4):593-6. PubMed ID: 12964040
[TBL] [Abstract][Full Text] [Related]
16. Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.
Sisley S; Smith K; Sandoval DA; Seeley RJ
Peptides; 2014 Aug; 58():1-6. PubMed ID: 24879927
[TBL] [Abstract][Full Text] [Related]
17. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
Mul JD; Begg DP; Barrera JG; Li B; Matter EK; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
Am J Physiol Regul Integr Comp Physiol; 2013 Jul; 305(1):R68-77. PubMed ID: 23616105
[TBL] [Abstract][Full Text] [Related]
18. Parabrachial Nucleus Contributions to Glucagon-Like Peptide-1 Receptor Agonist-Induced Hypophagia.
Swick JC; Alhadeff AL; Grill HJ; Urrea P; Lee SM; Roh H; Baird JP
Neuropsychopharmacology; 2015 Jul; 40(8):2001-14. PubMed ID: 25703200
[TBL] [Abstract][Full Text] [Related]
19. Effects of prolonged exendin-4 administration on entero-insular axis of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Macchi C; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
Int J Mol Med; 2003 Jun; 11(6):763-6. PubMed ID: 12736719
[TBL] [Abstract][Full Text] [Related]
20. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]